Caspase 3/8/9 Apoptotic Pathway Deregulation Analysis in Laryngeal Squamous Cell Carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Cell Death Research

Background:

• Caspases are key regulators of apoptosis (programmed cell death).
• Dysregulation of caspases is implicated in various cancers, including laryngeal squamous cell carcinoma (LSCC).
• Understanding caspase expression patterns in LSCC is crucial for developing targeted therapies.

Purpose of the Study:

• To co-analyze the protein expression levels of caspases 3, 8, and 9 in LSCC.
• To investigate the correlation between caspase expression and clinicopathological features of LSCC, such as grade and stage.

Main Methods:

• Analysis of tissue specimens from 50 LSCC cases.
• Immunohistochemistry and digital image analysis were employed to quantify caspase 3, 8, and 9 expression.
• Statistical analysis to assess differences in expression based on sex, grade, and stage.

Main Results:

• Median caspase 3 expression levels significantly decreased with increasing tumor stage (p = 0.033).
• While trends were observed for caspase 3/9 (higher in females) and caspase 3 (decreasing with grade), these did not reach statistical significance.
• No significant differences in caspase 8/9 expression were found concerning sex, grade, or tumor anatomical region.

Conclusions:

• Deregulation of caspases 3, 8, and 9 is common in LSCC.
• Progressive loss of caspase expression, particularly caspase 3, correlates with an aggressive LSCC phenotype.
• Targeted strategies to enhance caspase expression offer a promising therapeutic avenue for LSCC.